LAVA Medtech Acquisition Corp. Class A Common Stock
Compare this stock
LVAC Stock Report Card
$
29%
Performance
Score:
100/100
LVAC returned 3.41% in the last 12 months. Based on the other stocks in it's sector, it's performance is below average giving it a grade of 100 of 100.
Forecast
Score:
10/100
LVAC has no analyst ratings.
Technicals
Score:
10/100
LVAC does not have enough data to grade.
Volatility
Score:
100/100
LVAC had a 109.77% lower max drawdown compared to SPY over the last 12 months giving it a grade of 100 of 100.
Dividend
Score:
10/100
LVAC does not have a dividend payout ratio.
Profit
Score:
10/100
Could not get data for LVAC.
LAVA Medtech Acquisition Corp. Class A Common Stock Summary
Nasdaq / LVAC
Financial Services
Shell Companies
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
LVAC scored poorly on our reportcard. Here are some similar companies and how they performed.
